Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials
Written by: Rehan M. Hussain, MD November 2019 Maguire, AM, Russell S, Wellman JA. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials. Ophthalmology 2019 Sep;126(9):1273-1285. doi: 10.1016/j.ophtha.2019.06.017. Published online Jun 22, 2019. Voretigene neparvovec (VN) is a non-replicating adeno-associated virus (AAV), which has […]